Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 6:00 AM ET

Date/Time Source News Release
10/15/2021 04:01 PM EDT GlobeNewswire Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals
09/27/2021 09:10 AM EDT GlobeNewswire Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
09/02/2021 04:20 PM EDT GlobeNewswire Cellect Biotechnology Announces the ApoGraft(TM) Bone Marrow Transplantation of First Patient in U.S.
08/24/2021 04:16 PM EDT GlobeNewswire Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
08/13/2021 04:20 PM EDT GlobeNewswire The Securities and Exchange Commission Declared Cellect Biotechnology's Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals
06/16/2021 06:58 PM EDT GlobeNewswire Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin Pharmaceuticals
04/19/2021 08:00 AM EDT GlobeNewswire Cellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical Trial
03/29/2021 09:29 AM EDT GlobeNewswire Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
03/24/2021 05:26 PM EDT GlobeNewswire Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic Merger
11/20/2020 08:00 AM EST GlobeNewswire Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelerate Progress in 2021
Page